fda warning letter glp-1 october 2025 issued 30 letters to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's September crackdown on misleading FDA Grand Rounds | FDA

Generating 495 billion reais and surpassing the 455 billion from the previous year, the bar and restaurant sector in Brazil grew in 2025, with an increase that, when adjusted for inflation, was much more modest, at less than 1% in the country

Through the program, which runs through December 31, 2027, eligible Medicare beneficiaries can access certain GLP1 medications for $50 per month, offering more predictable and affordable pricing for patients who qualify

Silymarin will not counterbalance damage done by hepatitis B or D viruses

It's not just about losing weight

Q: What makes NMN5000 unique

SEMA: semaglutida subcutnea semanal 2,4mg